example muln… yeah short companies/ sorry scam companies.
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
US Stock MarketDetailed Quotes
VOR Vor Biopharma
- 1.270
- +0.432+51.55%
Close Dec 27 16:00 ET
- 1.270
- +0.000+0.01%
Post 19:59 ET
87.22MMarket Cap-0.77P/E (TTM)
1.270High0.920Low6.75MVolume0.990Open0.838Pre Close7.47MTurnover17.44%Turnover RatioLossP/E (Static)68.67MShares3.14052wk High1.20P/B49.16MFloat Cap0.63052wk Low--Dividend TTM38.71MShs Float63.620Historical High--Div YieldTTM41.77%Amplitude0.630Historical Low1.106Avg Price1Lot Size
Vor Biopharma Stock Forum
Sign in to post a comment
$Vor Biopharma (VOR.US)$ be quiet 🤫🤫🤫
2
$Vor Biopharma (VOR.US)$
Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial Design
• Preliminary data suggests improved relapse-free survival compared to published groups of acute myeloid leukemia (AML) patients at high risk of relapse post-transplant
• Trem-cel + Mylotarg continue to demonstrate engraftment, shielding, and broadened therapeutic window
...
Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial Design
• Preliminary data suggests improved relapse-free survival compared to published groups of acute myeloid leukemia (AML) patients at high risk of relapse post-transplant
• Trem-cel + Mylotarg continue to demonstrate engraftment, shielding, and broadened therapeutic window
...
2
1
$Vor Biopharma (VOR.US)$ Reuters· 1 min ago
Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback From FDA Regarding Registrational Trial Design
Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback From FDA Regarding Registrational Trial Design
1
$Vor Biopharma (VOR.US)$ 2.8 ////
2
3
$Vor Biopharma (VOR.US)$ up up up
3
2
$Vor Biopharma (VOR.US)$ So with yesterday’s move it has now completed a DB on the daily! Also since i posted the PR last week the daily volume has stayed well above the daily average for the last 90 days. But as always. If the chart is not saying trade me? Wait until it does.![]()
1
2
$Vor Biopharma (VOR.US)$ this stock will shoot up ! 🚀
3
$Vor Biopharma (VOR.US)$ aiya.goodnews but drop.
3
No comment yet
Krystian 1983 : 7 dollars om monday
小竜 OP Krystian 1983 :
